Coronary artery bypass surgery versus percutaneous interventions for women with multivessel coronary artery disease

Edward L Hannan1, Yifeng Wu1, Lamia Harik2

  • 1University at Albany, State University of New York, Albany, NY.

Insights

For women with multivessel coronary artery disease, coronary artery bypass graft surgery shows better long-term outcomes than percutaneous coronary intervention with everolimus-eluting stents, including reduced mortality and repeat procedures.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Multivessel coronary artery disease (CAD) affects many women.
  • Treatment decisions between percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG) surgery require careful consideration of patient outcomes.
  • Understanding long-term results is crucial for optimizing care in this demographic.

Purpose of the Study:

  • To compare the long-term effectiveness and safety of PCI with everolimus-eluting stents (EES) versus CABG surgery in women with multivessel CAD.
  • To evaluate differences in all-cause mortality, major adverse cardiac events, and repeat revascularization rates between the two treatment strategies.

Main Methods:

  • Retrospective, propensity-score matched cohort study utilizing the New York State cardiac registry (2012-2018).
  • Inclusion of women with multivessel CAD undergoing either PCI with EES or CABG surgery.
  • Primary outcome: all-cause mortality; Secondary outcome: major adverse cardiac events (all-cause mortality, myocardial infarction, stroke).

Main Results:

  • PCI with EES was associated with higher 6-year all-cause mortality (25.75% vs 23.57%) and major adverse cardiac events (36.58% vs 32.89%) compared to CABG.
  • PCI also showed higher rates of myocardial infarction (14.94% vs 9.12%) and repeat revascularization (21.53% vs 11.57%).
  • No significant difference in mortality was observed for PCI in cases of complete revascularization, noncomplex lesions, or in women without diabetes.

Conclusions:

  • For women with multivessel coronary artery disease, CABG surgery demonstrates superior long-term outcomes compared to PCI with EES.
  • CABG is associated with reduced 6-year mortality, myocardial infarction, and need for repeat revascularization.
  • PCI may be a viable option in specific subgroups, such as those without diabetes or with less complex disease.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...